Literature DB >> 12621009

Simple analytic method of 11C-flumazenil metabolite in blood.

Yasuhiro Magata1, Takahiro Mukai, Masafumi Ihara, Sadahiko Nishizawa, Haruhiro Kitano, Koichi Ishizu, Hideo Saji, Junji Konishi.   

Abstract

UNLABELLED: 11C-Flumazenil ((11)C-FMZ) is useful to estimate central benzodiazepine receptors by PET. The binding potential (BP) can be calculated with dynamic PET and continual blood sampling. Because conventional metabolite analysis of plasma samples is complicated and time consuming, a simple method is required to obtain an input function. In this article, a whole blood solvent extraction method was evaluated using data of 13 subjects.
METHODS: The plasma solvent extraction method was estimated in comparison with the thin-layer chromatography (TLC) method. Then, the whole blood solvent extraction method was evaluated in comparison with the plasma solvent extraction method.
RESULTS: Metabolite data analyzed by the plasma extraction method were well correlated with those by the TLC method (r = 0.99). The BP was calculated using both the whole blood extraction data and the plasma extraction data. No difference was observed in all brain regions.
CONCLUSION: This simple whole blood solvent extraction method can be applied to clinical BP estimation using (11)C-FMZ.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621009

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  2 in total

Review 1.  Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.

Authors:  Matteo Tonietto; Gaia Rizzo; Mattia Veronese; Masahiro Fujita; Sami S Zoghbi; Paolo Zanotti-Fregonara; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

2.  Association of vascular parkinsonism with impaired neuronal integrity in the striatum.

Authors:  M Ihara; H Tomimoto; K Ishizu; H Yoshida; N Sawamoto; K Hashikawa; H Fukuyama
Journal:  J Neural Transm (Vienna)       Date:  2007-01-18       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.